Diagens (02526.HK): Admitted as Constituent to Hang Seng Composite Index and 22 Other Hang Seng Indices
NewTimeSpace News: On August 24, 2026,Diagens(02526.HK) announced that it has been selected by Hang Seng Indexes Company Limited as a constituent of 23 Hang Seng indices. Among them, the Hang Seng Composite Index and Hang Seng Composite LargeCap & MidCap Index take effect on September 7, 2026; the Hang Seng Biotech Index and Hang Seng Stock Connect AI Thematic Index become effective on September 14, 2026.
Diagensstated that the inclusion recognises its long-term growth potential by the capital market. It is expected to diversify the investor base, boost trading liquidity and strengthen risk resilience.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- DIAGENS-B(02526.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 55.88 million, loss widened by 4070.37% YoY
- Diagens-B (02526.HK): Core Product AI AutoVision® Obtains NMPA Class III Medical Device Registration Certificate
- NewTimeSpace | Diagens (02526.HK) Stock Price Triples Two Weeks After Listing; Net Losses and Competitive Risks Coexist Under High Valuation
